Access for Life's vision is to facilitate therapies that require repetitive vascular access (RVA) for chronic disease patients. Our patented JEM ™ devices technology & design will preserve the vessel wall & reduce clinical complications due to vessel wall damage e.g. perforation, pseudoaneurysms, hematomas, stenosis & thrombosis, reducing morbidity mortality& costs.
JEM: easier & safer RVA for hemodialysis & chemotherapy & continuous chronic intravenous infusion in adult & pediatric patients.